Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Didi IPO: 7 Things to Know About DIDI Stock Ahead of Its NYSE Launch

Here's what investors interested in the upcoming Didi IPO may want to know about this Chinese ride-hailing company.

ORPH Stock: The Big News That Has Red-Hot Orphazyme Gaining Today

Two key announcements from Orphazyme are sending shares of ORPH stock higher today, as investors continue to reprice this biopharma stock.

XELA Stock: The News That Has Short-Squeeze Play Exela Rocketing Today

Today's robotics process announcement has sent shares of XELA stock soaring more than 40% amid heightened retail investor interest.

Didi IPO: When Does Didi Go Public? What Is the DIDI Stock IPO Price Range?

Here's what investors may want to know about the upcoming and highly anticipated Didi IPO scheduled to take place this week.

NCLH, RCL, CCL Stocks: Why Are Cruise Stocks Down Today?

Two passengers tested positive for Covid-19, sending cruise stocks like CCL stock down on Monday. Here's what you need to know.